Home › Harbour Antibodies Announces First U.S. Patent For Novel Transgenic Mouse Antibody Technology For Next Generation Therapeutic Antibody Discovery
 

Keywords :   


Harbour Antibodies Announces First U.S. Patent For Novel Transgenic Mouse Antibody Technology For Next Generation Therapeutic Antibody Discovery

2014-12-29 01:22:41| drugdiscoveryonline Home Page

Harbour Antibodies BV announced the issuance of the first U.S. Patent (No. 8,883,150) covering the company’s HCAb mouse platform for producing human “heavy chain only” antibody molecules

Tags: technology generation mouse patent

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Exploring the future of agriculture
15.05American, Mexican, and Canadian cattle producers sign joint statement
15.05Attitudes EWG Verified Skincare Line Oceanly Expands with SPF Offerings
15.05Sherwin-Williams Packaging Coatings Expands Non-BPA Coatings Production in Europe
15.05Voesh Unveils Body Refining Roller Crme Ahead of Summer 2024
15.05KANSAI HELIOS Completes Acquisition of WEILBURGER Coatings
15.05TSCRA Disaster Relief Fund distributes $900,000 in financial assistance
15.05Portugal\'s Etifam adds Screen Truepress Label 350UV SAI-E
More »